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Exome Sequencing Identifies SLC24A5 as a Candidate
Gene for Nonsyndromic Oculocutaneous Albinism
Ai-Hua Wei1,2,4 , Dong-Jie Zang1,4, Zhe Zhang1,4, Xuan-Zhu Liu3,4, Xin He1, Lin Yang1, Yi Wang1,
Zhi-Yong Zhou1, Ming-Rong Zhang3, Lan-Lan Dai3, Xiu-Min Yang2 and Wei Li1
Oculocutaneous albinism (OCA) is a heterogeneous and autosomal recessive disorder with hypopigmentation in
the eye, hair, and skin color. Four genes, TYR,OCA2, TYRP1, and SLC45A2, have been identified as causative genes
for nonsyndromic OCA1–4, respectively. The genetic identity of OCA5 locus on 4q24 is unknown. Additional
unknown OCA genes may exist as at least 5% of OCA patients have not been characterized during mutational
screening in several populations. We used exome sequencing with a family-based recessive mutation model
to determine that SLC24A5 is a previously unreported candidate gene for nonsyndromic OCA, which we
designate as OCA6. Two deleterious mutations in this patient, c.591G4A and c.1361insT, were identified.
We found apparent increase of immature melanosomes and less mature melanosomes in the patient’s skin
melanocytes. However, no defects in the platelet dense granules were observed, excluding typical Hermansky–
Pudlak syndrome (HPS), a well-known syndromic OCA. Moreover, the SLC24A5 protein was reduced in steady-
state levels in mouse HPS mutants with deficiencies in BLOC-1 and BLOC-2. Our results suggest that SLC24A5 is a
previously unreported nonsyndromic OCA candidate gene and that the SLC24A5 transporter is transported into
mature melanosomes by HPS protein complexes.
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INTRODUCTION
Oculocutaneous albinism (OCA) is a heterogeneous and
autosomal recessive disorder. Its worldwide prevalence is
approximately 1:17,000 (Witkop, 1979), indicating that
about 1 in 65 people carries the OCA gene. It manifests
as a reduction or complete loss of melanin in the skin,
hair, and eyes, often accompanied with eye symptoms such
as photophobia, strabismus, moderate-to-severe visual
impairment, and nystagmus (Gronskov et al., 2007). The
characterization of OCA subtypes previously based upon
clinical manifestations has evolved into a molecular
classification on the basis of the identification of the
causative genes (Wei et al., 2010). OCA has been identified
as arising from mutations in nonsyndromic OCA genes (TYR,
OCA2, TYRP1, and SLC45A2) or syndromic OCA genes (HPS1,
AP3B1, HPS3, HPS4, HPS5, HPS6, DTNBP1, BLOC1S3,
PLDN, LYST, MYO5A, RAB27A, and MLPH; Li et al., 2006;
Wei and Li, 2012). Although several melanosomal protein
encoding genes such as RAB38, TYRP2, PMEL, and SLC24A5
are suggestive of candidate OCA genes in the mouse or other
species (Sitaram and Marks, 2012), no pathological mutations
of these genes have been reported in human OCA patients
(Suzuki et al., 2003; Hutton and Spritz, 2008; Gronskov et al.,
2009; Sengupta et al., 2010). More candidate OCA genes in
humans are likely to be identified as suggested by additional
mouse OCA genes (Bennett and Lamoreux, 2003; Li et al.,
2006). In addition, unknown loci are implicated in human OCA
patients. Recently, a region on 4q24 has been identified
as an additional locus (OCA5) for nonsyndromic OCA
(Kausar et al., 2012). However, its genetic identity has not
been characterized. It is plausible to predict that unknown OCA
genes will be uncovered.
We performed molecular screening of 179 OCA patients in
the Chinese Albinism Registry by implementing the optimized
strategy (Wei et al., 2010, 2011). We did not find any
mutation in the commonly occurring OCA genes (TYR,
OCA2, TYRP1, SLC45A2, HPS1, and HPS4) in 11 patients
after sequencing all the exons and the adjacent exon-intron
boundaries of these genes. The percentage of unidentified
mutations (6.2%, 11/179) is similar to that observed in
other studies (Hutton and Spritz, 2008; Rooryck et al., 2008).
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This suggests that additional unknown OCA genes may exist.
In this study, we adopted the next-generation sequencing
method and identified SLC24A5 as the putative causative gene
in one OCA6 (named subsequent to the OCA5 locus) family.
RESULTS
Clinical features of the OCA6 patient
In this OCA6 family (Supplementary Figure S1 online), the
proband (IV2 in the pedigree) was clinically diagnosed as
OCA2 at the age of 3 years (Patient# 3 in Supplementary Table
S1 online). Her hair at birth was blonde but darkens to brown
at a later age (Figure 1a). Her skin was white and her iris was
transparent and brownish (Figure 1b). Nystagmus and
photophobia were mild in this proband. Her visual acuity was
20/100. Color fundus photography showed hypopigmentation
and underdeveloped macula (Figure 1c). Optical coherence
tomography showed disappearance of central fovea of macula
(Figure 1d) when compared with her brother. This patient
has no history of bleeding tendency or clinical episodes for
hemorrhagic diathesis including purpura. The counts for
platelets, red blood cells, and white blood cells were within
the normal ranges. The percentages of granulocytes, lympho-
cytes, and monocytes were within normal ranges as well.
Measurements of serum IgG, IgA, IgM, C3, and C4 were
within the normal ranges. All the coagulation tests including
activated partial thromboplastin time, prothrombin time,
thrombin time, D-dimer, and fiborinogen were within normal
ranges. Trace metals (Cu, Zn, Ca, Mg, and Fe) in peripheral
blood were within the normal ranges. Other serum and urine
metabolites were within the normal ranges. No other apparent
malformation in physical examinations was found. Normal
images were shown by chest X-ray, head computerized
tomography scan, and abdomen B-ultrasound scan.
No neurological symptoms were found. Taken together,
this proband has symptoms of nonsyndromic OCA. No
consanguineous marriage was claimed by her parents
(Supplementary Figure S1 online). OCA symptoms were not
apparent in her parents and brother (Figure 1).
Two pathological alleles of the SLC24A5 gene were found
in the OCA6 patient
We performed exome sequencing of the patient (or proband)
together with her parents. The called variants include single-
nucleotide polymorphisms (SNPs) and Indels. SNPs are called
by the SOAPsnp program (Li et al., 2009). Indels are called
by the Genome Analysis Toolkit (McKenna et al., 2010).
The conflicted sites between SNPs and Indels are filtered out.
We exclude the variants with quality score less than 20. In our
highest priority, the SNPs/Indels in coding regions or splicing
sites are put into the next filtering pipelines to exclude
variants with synonymous mutations or those in 30-
untranslated region, 50-untranslated region, intronic, and
intergenic regions implemented by the predictions of the
SIFT program (http://sift.jcvi.org/). The remaining SNPs/Indels
are then filtered against three databases: dbSNP (v130), 1000
Genomes Project database, and HapMap to exclude the
variants with an allelic frequency larger than 0.5%. Finally,
the filtered targeted SNPs/Indels are classified according to
their genotypes for subsequent analyses. The results are
summarized in the Supplementary Tables S2 and S3 online.
With this candidate gene list (30 genes in total after filtering
by our pipeline as shown in Supplementary Table S3 online),
we first focused on whether there are any known pigment
genes (96 selected genes from the literature or database)
that have been described in human and mice (Bennett and
Lamoreux, 2003; Li et al., 2006; Sturm, 2009; Yamaguchi
and Hearing, 2009; Ito and Wakamatsu, 2010, 2011; Sitaram
and Marks, 2012). That is, we checked whether any of the
96 pigmentary genes appears either in the compound
heterozygous state (23 genes) or in the homozygous state
(7 genes; Supplementary Table S3 online). We found that only
Patient Normal
Figure 1. Clinical features of oculocutaneous albinism in the OCA6 patient
(left panel) compared with her unaffected brother (right panel). (a) Brown
or dark-brown hair in the OCA6 patient compared with the dark hair in her
brother. (b) Transparent and brown-tinted iris in the OCA6 patient compared
with the dark iris in her brother. (c) Hypopigmentation in retina and
underdeveloped macula in the OCA6 patient compare with a normal
pigmented retina. Arrowheads show the maculae. (d) Disappearance of central
fovea of macula in the OCA6 patient. A concave shape of normal central
fovea of macula in her brother is shown by optical coherence tomography.
Arrowheads indicate the location of foveas. The subjects in the photographs
provided written, informed consent for publication of their photographs.
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one known pigmentary gene, SLC24A5, appeared at the
heterozygous state in this paired match. Two variations in
this patient, c.591G4A and c.1361insT, were shown in our
exome sequencing data. We further verified these two
previously unreported mutations by Sanger sequencing. In
this family, the proband inherited the c.1361insT mutation
from her father, and the c.591G4A mutation from her mother.
Her brother is a heterozygote of the c.591G4A mutation
(Figure 2). We also detected the c.591G4A mutation in the
maternal side of this family (Supplementary Figure S1 online).
We found that III3 is the carrier of the c.591G4A mutation,
but II2 and III2 do not carry this mutation. We did not detect
the c.1361insT mutation in the remaining paternal family
members because of unavailability of samples (Supplementary
Figure S1 online). These two mutations of SLC24A5 were not
found in 120 unaffected individuals. No SLC24A5 mutation
was found in the remaining 10 unidentified OCA patients as
shown in Supplementary Table S1 online. This suggests that
OCA6 occurs at a relatively lower frequency (0.56%, 1/179)
in Chinese OCA patients compared with OCA1, OCA2,
OCA4, and HPS1. In a total of 179 OCA patients from the
Chinese Han population, OCA1, OCA2, OCA4, and HPS1
account for 64.3%, 11.7%, 15.6%, and 2.2%, respectively
(Wei et al., 2010, 2011). The c.591G4A mutation predicts a
nonsense mutation, p.W197X, on exon 6. The c.1361insT
mutation leads to a truncated protein (p.L454Ffs31X) due
to a premature stop codon at 486X on exon 9, instead
of the wild-type protein at 501X. By using the PROVEAN
algorithm (http://provean.jcvi.org), both truncated proteins are
predicted to be deleterious to the function of the SLC24A5
transporter.
Less mature melanosomes were present in the skin melanocytes
of the OCA6 patient
To investigate whether the SLC24A5 mutations affect pigment
synthesis, we examined the morphology of melanosomes
in epidermal melanocytes by electron microscope (EM).
We observed less mature melanosomes (stage IV) but more
immature melanosomes (stages I, II, and III) in both the cell
body and bulges extending to keratinocytes (Figure 3a and c)
compared with the control sample (Figure 3b and d). This
suggests that the SLC24A5 protein is required for the
maturation of melanosmes or for the production of pigment
in mature melanosomes. The less mature melanosomes
likely produce less pigment in the skin and hair. We then
measured eumelanin content in the patient’s hair by
HPLC. Indeed, the hair eumelanin content is significantly
lower in the patient compared with her brother and
parents (Figure 3e). This suggests that the brown hair of the
patient is likely due to the loss of eumelanin rather than the
production of more pheomelanin, a feature existed in
the clinically diagnosed OCA2 patients with mutations of
two other melanosomal transporters, OCA2 and SLC45A2
(Ito et al., 2011).
The defects in OCA6 melanosomes phenocopy the
disruption of melanosome biogenesis in Hermansky–Pudlak
syndrome (HPS; Nguyen et al., 2002). HPS, a group of
syndromic OCA, affects a group of lysosome-related
organelles. The gold standard in diagnosing HPS is the lack
of platelet dense granules by EM (Wei and Li, 2012). Our
results showed that the number and size of platelet dense
granules in the OCA6 patient were normal. In addition, no
apparent changes in the dermal structure were noted in the
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Figure 2. Mutational alleles of SLC24A5 verified by Sanger sequencing. The simplified pedigree is shown in the middle. An arrow indicates the proband
who inherited the c.1361insT on exon 9 (E9) from her father and the c.591G4A on exon 6 (E6) from her mother. Her brother inherited the c.591G4A mutation
from her mother. Arrows embedded in the sequencing graphs indicate the sites of nucleotide changes.
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patient (Supplementary Figure S2 online). This further
excludes OCA6 as a subtype of HPS.
Steady-state levels of SLC24A5 were reduced in the skin of HPS
mouse mutants
SLC24A5 has been reported as a melanosomal protein, which
regulates pigment synthesis (Lamason et al., 2005). How this
protein is transported into mature melaonsome to function in
pigmentation remains unknown. Several melanosomal
proteins such as tyrosinase, TYRP1, OCA2, and ATP7A are
transported into mature melanosomes mediated by HPS
protein–associated complexes such as AP-3, BLOC-1, and
BLOC-2 as summarized in a recent review (Wei and Li,
2012). We measured the steady-state levels of SLC24A5
in mouse mutants of BLOC-1 (pallid, pa), BLOC-2 (ruby-
eye, ru), BLOC-3 (pale ear, ep), and AP-3 (pearl, pe).
Interestingly, the steady-state levels of SLC24A5 are reduced
in HPS mutants pa and ru but are not significantly changed in
ep and pe, although a reduction tendency was seen in ep
(Figure 4). This suggests that BLOC-1 and BLOC-2 may
function in mediating the melanosomal targeting of SLC24A5.
Deficiency in any of these complexes may lead to the
mistargeting of SLC24A5, which may be degraded by lyso-
somes or proteosomes. Clearly, the underlying trafficking
mechanisms of SLC24A5 warrant further investigation.
DISCUSSION
SLC24A5 (solute carrier family 24, member 5), a putative
potassium-dependent sodium/calcium exchanger 5 (NCKX5),
has been implicated in hypopigmentation. It may function
in the calcium homeostasis of melanosomes or trans-Golgi
network, which is required for melanin biosynthesis or
melanosomal protein trafficking (Lamason et al., 2005;
Ginger et al., 2008). Genome-wide association study of skin
pigmentation variation in individuals of the South Asian
ancestry has revealed that SLC24A5 SNP rs1426654
(Thr111Ala) is associated with skin pigmentation (Stokowski
et al., 2007). The allele p.Ala111Thr of the SLC24A5 gene is
nearly fixed in light-skinned Europeans and can be considered
as an ancestry informative marker (Soejima and Koda, 2007).
Switching Thr for Ala at residue 111 of SLC24A5 reduces its
exchange activity and melanogenesis (Ginger et al., 2008).
Furthermore, SLC24A5 knockdown reduces melanin produc-
tion in mouse B16 melanocytes. This suggests that the activity
of this transporter regulates melanin synthesis and human skin/
hair color with an undefined mechanism.
In Slc24a5-knockout mice, ocular albinism and hypopig-
mentation features have been reported (Vogel et al., 2008).
Similarly, dysmorphic melanosomes are characterized in
golden zebrafish mutant (Lamason et al., 2005). These
results implicate that the SLC24A5 mutation may cause
OCA symptoms in humans. However, analyses of SLC24A5
did not reveal pathological mutations in OCA patients
(Gronskov et al., 2009; Sengupta et al., 2010). Recently, in
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Figure 3. Electron micrographs of epidermal melanocytes and histograph of
eumelanin measurements. Fewer mature melanosomes are present in the cell
body (a) and bulge (c) in the OCA6 patient compared with a 13-year-old boy
with normal skin (b, d). Arrows indicate mature melanosomes (stage IV),
arrowheads show immature melanosomes (stage I, II, or III). Bars in a and b:
1mm, in c and d: 500 nm. (e) Hair eumelanin contents of the OCA6 family
members. The eumelanin content of the patient or proband (P) is significantly
lower compared with that of her father (F), mother (M), or brother
(B; *Po0.05). Six samples (n¼ 6) of each individual were determined by
HPLC. Data are represented as mean±SD.
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Figure 4. Immunoblotting of skin SLC24A5 in mouse Hermansky–Pudlak
syndrome (HPS) mutants. (a) Lysates of skin from C57BL/6J (B6, wild-type),
pallid (pa, BLOC-1-deficient HPS9 mutant), ruby eye (ru, BLOC-2-deficient
HPS6 mutant), pale ear (ep, BLOC-3-deficient HPS1 mutant), and pearl (pe,
AP-3-deficient HPS2 mutant) mice were subjected to immunoblotting probed
by anti-SLC24A5. A 43 kDa band of SLC24A5 is shown. b-Actin serves as a
loading control. (b) The SLC24A5 band intensities were measured from three
independent replicates, normalized to b-actin levels, and converted to the
percentage of the mean normalized value of wild-type lysates. Data are
represented as mean±SD. Note significant reductions of steady-state levels of
SLC24A5 in pa and ru. The changes in ep and pe are not significant.
***Po0.005; **Po0.01.
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an Indian patient with extreme cutaneous hypopigmentation,
a homozygous four-nucleotide insertion (c.569_570insATTA)
was found in the SLC24A5 gene. The insertion leads to a
premature stop codon at 193X, suggesting a deleterious
mutation of the SLC24A5 gene. However, this individual
has pinkish-white skin, but dark brown hair and no apparent
ocular defects (Mondal et al., 2012), excluding it from a
typical form of OCA. A genotype–phenotype effect
(i.e., different genotypes of SLC24A5 may produce variation
of phenotypes) may exist or other pigmentary genes may
influence its manifestations on the pigmentation of hair and
eye in this case or in the Indian population. In addition, it
requires detail ophthalmological examinations of this Indian
patient to see whether ocular albinism occurs. In this study,
the antibody used in detecting mouse skin SLC24A5 and
several other commercial anti-human SLC24A5 antibodies did
not produce a specific signal in normal human skin tissues.
This precluded us from evaluating SLC24A5 protein changes
in our OCA6 patient. Nevertheless, considering the functional
studies and the phenotypes in the Slc24a5-KO mice (Vogel
et al., 2008) and golden zebrafish (Lamason et al., 2005),
it is likely that the ultrastructural changes of melanosomes in
our OCA6 patient result from the observed SLC24A5
mutations in a compound heterozygous state. Therefore, to
our knowledge, the deleterious mutation of SLC24A5 causes a
previously unreported subtype of nonsyndromic OCA, OCA6.
In our OCA6 patient, more premature melanosomes were
noted in epidermal melanocytes (Figure 3), implicating that
SLC24A5 is involved in the maturation of melanosomes,
mimicking a typical feature of the HPS and the Chediak–
Higashi syndrome (Huizing et al., 2008; Wei and Li, 2012).
Our results suggest that several HPS protein complexes
(BLOC-1 and BLOC-2) may be involved in SLC24A5
trafficking into mature melanosomes. This is a well-defined
pathway to mediate the trafficking of TYRP1, OCA2, and
ATP7A into mature melanosomes, in which BLOC-2 functions
downstream of BLOC-1 (Setty et al., 2007, 2008; Bultema
et al., 2012). The assembly of SLC24A5 into melanosomes
appears important for melanosomal architecture to ensure that
melanin is synthesized properly. Lack of SLC24A5 may lead to
the disruption of melanosomal maturation and melanin
synthesis. In contrast, deficiency of HPS protein complexes
(e.g., BLOC-1 and BLOC-2) may disrupt the targeting of
SLC24A5 into melanosomes, a possible explanation to the
OCA symptoms in HPS. These findings provide insights into
the pathogenesis of nonsyndromic OCA and HPS. Mutational
screen of SLC24A5 is recommended in the genetic analyses
of OCA patients.
MATERIALS AND METHODS
Study subjects
We recruited 11 molecularly uncharacterized OCA patients from the
179 unrelated OCA patients in the Chinese Albinism Registry (Wei
et al., 2010, 2011) and 120 unaffected subjects from the Chinese Han
population. Typically, among clinically diagnosed OCA1 patients,
OCA1A presents with white hair that does not change with age, and
OCA1B is characterized by white hair at birth that later becomes light
yellow or darker. OCA2 is characterized by yellow, brown, or blonde
hair at birth that may darken at a later age (Oetting et al., 2003). In all
11 OCA patients, white skin, blue or brown irises, and mild-to-severe
nystagmus were observed (Supplementary Table S1 online).
Only Patient #1 has consanguineous parents. Patient #3 is described
in more detail in the Results. Blood samples were collected from
these patients and their family members. This study was approved by
the internal review board of the Bioethics Committees of Beijing
Tongren Affiliated Hospital of Capital Medical University and the
Institute of Genetics and Development Biology (IGDB), Chinese
Academy of Sciences (CAS). The study was conducted according to
the Declaration of Helsinki Principles. Written informed consent was
obtained and 8 ml peripheral blood samples were collected from
all subjects participating in this study.
Mice
The HPS mouse mutants, pallid (pa, BLOC-1 deficiency), ruby eye
(ru, BLOC-2 deficiency), pale ear (ep, BLOC-3 deficiency) and pearl
(pe, AP-3 deficiency), and wild-type control C57BL/6J (B6) were
originally from the Jackson Laboratory (Bar Harbor, ME) and main-
tained in Dr Richard Swank’s laboratory at Roswell Park Cancer
Institute (Buffalo, New York) and are now maintained at IGDB, CAS.
All procedures were approved by the Institutional Animal Care and
Use Committee of IGDB. To ensure the genotypes of the mouse
mutants, we developed PCR methods for genotyping on the basis of
the mutational nature of these mutants (Li et al., 2006).
Exome sequencing
Total genomic DNA was extracted from blood samples by the routine
proteinase K/SDS method. DNA concentration of each sample is
more than 200 ngml 1 in a total of at least 15mg with OD260/280
from 1.8 to 2.0 for quality assurance. Exons are captured with a
specificity over 95% by following the procedures of the Agilent
SureSelect Human All Exon Kits (Agilent, Santa Clara, CA). Sequen-
cing was performed on an Illumina Solexa HiSeq 2000 instrument
according to Illumina’s protocol (Illumina, San Diego, CA). The total
targeted region of each sample is around 50 Mb. The mean depth of
the target region is 40–50X. The average read length is around 90 bp.
Reads were aligned to the human reference genome sequence UCSC
Santa Cruz hg18, build 36.1 via the Burrows–Wheeler Aligner
program (Li and Durbin, 2010). We implemented a data analysis
framework with the family-based autosomal recessive mutation
model, which is described in detail in Results.
Sanger sequencing of PCR products and validation of previously
unidentified mutations
Standard PCR amplification procedures were conducted as previously
described (Wei et al., 2010, 2011). All PCR product sizes were verified
by 1.0–1.2% agarose gel electrophoresis. The primer sequences for
the amplification of nine exons and exon/intron boundaries of the
human SLC24A5 gene are available upon request. For Sanger sequenc-
ing, all purified PCR products were sequenced using the ABI PRISM
3700 automated sequencer (Applied Biosystems, Foster City, CA).
Histopathological examinations
The biopsy samples of skin tissue from abdomen were fixed with 10%
neutral-buffered formalin for histological observation or with 2.5%
glutaraldehyde in phosphate buffer (pH7.4) for ultrastructural obser-
vation (Yang et al., 2012). The formalin-fixed samples were
A-H Wei et al.
SLC24A5 Mutation in OCA
1838 Journal of Investigative Dermatology (2013), Volume 133
dehydrated, embedded in paraffin, sectioned at 5mm thickness with
a Leica microtome (Leica, Hubloch, Germany). Slides were stained
with hematoxylin and eosin, and then observed under a light
microscope (Nikon, Tokyo, Japan).
For EM, the glutaraldehyde-fixed samples of skin tissue were
postfixed in 1% OsO4 for 2 hours at room temperature. These samples
were dehydrated through a graded series of acetone incubations and
embedded in Spurr’s resin, polymerized at 70 1C for 12 hours. Tissues
were sectioned to 65 nm with a diamond knife (Diatome, Biel,
Switzerland) on a Leica UC7 ultramicrotome (Leica) and mounted
on Formvar-coated copper grids. After sequential staining with uranyl
acetate and lead citrate, the ultrastructure was examined on a
transmission EM (JEM-1400, JEOL, Tokyo, Japan) operated at 80 KV
and digital images were captured with a 4 k 2.7 k pixels CCD
camera (Gatan, Tokyo, Japan).
To observe the dense granules in platelets, venous blood samples
from the patient and her brother were collected with vacuum blood
collection tubes containing EDTA-K2. The blood samples were
centrifuged at 150 g for 10 minutes at room temperature to enrich
platelets. A drop of platelet-rich plasma was placed on a carbon-
coated grid and, 30 seconds later, the liquid was blotted carefully
with Whatman#3 filter paper (PGC Scientifics, Palm Desert, CA).
Grids were viewed without staining on the JEM-1400 EM.
Hair eumelanin measurement by HPLC
The quantification of eumelanin was based on the formation of the
specific degradation product, pyrrole-2,3,5-tricarboxylic acid by
alkaline H2O2 oxidation of eumelanin (Ito et al., 2011; Yang et al.,
2012). In brief, 1.0–1.5 mg of hair cut at the length of 2–3 mm was
placed in 2 ml screw-capped test tubes, to which 375ml of 1 mol l 1
K2CO3 and 25ml of 30% H2O2 (final concentration: 1.5%) were
added. Samples were mixed at room temperature for 20hours. Residual
H2O2 was decomposed by the addition of 50ml of 10% Na2SO3 and
the mixtures were then acidified with 140ml of 6 mol l 1 HCl. After
vortex-mixing, the reaction mixtures were centrifuged at 4,000 g for
1 minutes and aliquots (20ml) of the supernatant fluids were directly
injected into the HPLC system (Waters 1525, Waters, Dublin, Ireland)
using a Symmetry C18 column (4.6 mm 250 mm, 5mm, Waters).
The mobile phase was 0.1 mol l 1 potassium phosphate buffer (pH
1.9): MeOH, 99: 1 (v/v). Analyses were performed at 35 1C at a flow
rate of 0.7 ml min 1. Absorbance of the eluent was monitored at
269 nm with a UV detector. The pyrrole-2,3,5-tricarboxylic acid
standard was a gift from Dr. Kazumasa Wakamatsu.
Steady-state level of protein by immunoblotting
Tissues from wild-type or mutant mice at a 3-month age were
homogenized in a lysis buffer containing 50 mM Tris-HCl, pH 7.4,
150 mM NaCl, 1% Triton X-100, supplemented with proteinase
inhibitor cocktail (Sigma-Aldrich, St Louis, MO). The extracts were
centrifuged at 15,000 g for 15 minutes, and the concentration of the
solublized protein was determined with the Protein Assay (Bio-Rad,
Hercules, CA). For detection of various proteins in tissue homo-
genates, equal amounts of tissue homogenates were separated in
SDS-PAGE gels and immunoblotted by a standard procedure, probed
with goat anti-mouse SLC24A5 antibody (Abcam, Cambridge, MA),
and visualized by ECLþ staining (Amersham Biosciences,
Piscataway, NJ). Loading controls were probed with anti-b-actin
antibody (Sigma-Aldrich).
Statistics
For melanin measurements, statistical significance was determined
by performing the Student’s t-test. For semiquantitative analysis
of immunoblots, protein bands detected by ECLþ were scanned
into Adobe Photoshop, and intensities were analyzed using NIH
Image J and the Student’s t-test. P values o0.05 were considered as
significant.
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